Cargando…
Drug Repurposing to Inhibit Histamine N-Methyl Transferase
Lower activity of the histaminergic system is associated with neurological disorders, including Alzheimer’s disease (AD). Thus, the enhancement of histaminergic neurotransmission by inhibition of histamine N-methyl transferase (HNMT), which degrades histamine, appears as an important approach. For t...
Autores principales: | Jiménez, Elvia Mera, Żołek, Teresa, Hernández Perez, Paola Gabriela, Miranda Ruvalcaba, Rene, Nicolás-Vázquez, María Inés, Hernández-Rodríguez, Maricarmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867436/ https://www.ncbi.nlm.nih.gov/pubmed/36677633 http://dx.doi.org/10.3390/molecules28020576 |
Ejemplares similares
-
Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer’s Disease
por: Flores-Clemente, Cecilia, et al.
Publicado: (2021) -
In Vitro and Computational Studies of Perezone and Perezone Angelate as Potential Anti-Glioblastoma Multiforme Agents
por: Hernández-Rodríguez, Maricarmen, et al.
Publicado: (2022) -
Computational Studies of Aflatoxin B(1) (AFB(1)): A Review
por: Martínez, Joel, et al.
Publicado: (2023) -
Synthesis, Cytotoxic Activity and In Silico Study of Novel Dihydropyridine Carboxylic Acids Derivatives
por: Ballinas-Indilí, Ricardo, et al.
Publicado: (2023) -
The Ability of Chlorophyll to Trap Carcinogen Aflatoxin B(1): A Theoretical Approach
por: Vázquez-Durán, Alma, et al.
Publicado: (2022)